Search research articles
Contact Us
Filters
Showing results (101-110 of 106) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 106 results.
Cancer Research Communications
|
November 10, 2025
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer
Jongchan Park, Sangwon Shin, Woochan Hwang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2019
Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population
Seung Shin Park, Se Song Jang, Chang Ho Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
Yeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, et al.
Diabetes, Obesity & Metabolism
|
December 28, 2016
Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study)
Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
April 6, 2021
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Jeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 106) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 106 results.
Cancer Research Communications
|
November 10, 2025
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer
Jongchan Park, Sangwon Shin, Woochan Hwang, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 13, 2019
Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population
Seung Shin Park, Se Song Jang, Chang Ho Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 16, 2024
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as a Potential Biomarker for Immune Checkpoint Inhibitors in Patients with Biliary Tract Cancer
Yeong Hak Bang, Choong-Kun Lee, Kyunghye Bang, et al.
Diabetes, Obesity & Metabolism
|
December 28, 2016
Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study)
Chang Ho Ahn, Kyung Ah Han, Jae Myung Yu, et al.
Endocrinology and Metabolism (Seoul, Korea)
|
April 6, 2021
Diagnosis for Pheochromocytoma and Paraganglioma: A Joint Position Statement of the Korean Pheochromocytoma and Paraganglioma Task Force
Eu Jeong Ku, Kyoung Jin Kim, Jung Hee Kim, et al.
Journal for Immunotherapy of Cancer
|
February 14, 2024
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Jeanne Shen, Yoon-La Choi, Taebum Lee, et al.
Page
of 11